EP TECHNOLOGIES BEGINS SELLING RF CARDIAC ABLATION SYSTEM FOLLOWING FDA APPROVAL; MEDTRONIC ATAKR RF SYSTEM SLATED TO GO BEFORE DECEMBER PANEL
This article was originally published in The Gray Sheet
Executive Summary
EP Technologies is the first to market with an approved radiofrequency ablation system for treatment of tachyarrhythmias. On Oct. 31, FDA gave the firm a green light to begin sales of its RF Cardiac Ablation System.